PE ratio:
16.25+3.40(+26.46%)Summary
- As of today (May 18, 2025), ACAD price to earnings ratio is 16.25, with a rise of +3.40 (+26.46%) during the most recent trading session on May 16, 2025.
- ACAD PE ratio is now -84.98% below its all-time high of 108.22.
Performance
ACAD PE ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PE ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
ACAD PE ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +26.5% | +26.5% | +0.7% | +4.0% |
| 1 m1 month | +52.7% | +52.8% | - | - |
| 3 m3 months | +10.2% | +11.1% | +0.7% | +4.0% |
| 6 m6 months | -24.4% | +32.7% | - | - |
| ytdytd | +19.2% | +21.3% | - | - |
| 1 y1 year | - | +49.9% | +10000.0% | +22.4% |
| 5 y5 years | - | -56.2% | +186.7% | +172.1% |
ACAD PE ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 16.25 | at high | 10.47 | +55.2% |
| 3 m | 3-month | 16.25 | at high | 10.29 | +57.9% |
| 6 m | 6-month | 24.18 | -32.8% | 10.29 | +57.9% |
| 1 y | 1-year | 108.22 | -85.0% | 10.29 | +57.9% |
| 3 y | 3-year | 108.22 | -85.0% | 10.29 | +57.9% |
| 5 y | 5-year | 108.22 | -85.0% | 10.29 | +57.9% |
| alltime | all time | 108.22 | -85.0% | 2.19 | +642.0% |
ACAD PE ratio History
| Date | Value |
|---|---|
| 2025 | 16.25(+19.2%) |
| Date | Value |
|---|---|
| 2024 | 13.63(+354.3%) |
| 2010 | 3.00 |
FAQ
- What is ACADIA Pharmaceuticals price to earnings ratio?
- What is the all time high PE ratio for ACADIA Pharmaceuticals?
- What is ACAD price to earnings ratio year-to-date change?
What is ACADIA Pharmaceuticals price to earnings ratio?
The current PE ratio of ACAD is 16.25
What is the all time high PE ratio for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high price to earnings ratio is 108.22
What is ACAD price to earnings ratio year-to-date change?
ACADIA Pharmaceuticals price to earnings ratio has changed by +2.62 (+19.22%) since the beginning of the year